Angiogenesis and angiogenic mediators in haematological malignancies

This publication has 47 references indexed in Scilit:

• Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
  New England Journal of Medicine, 1999
• True
  Leukemia, 1999
• What Is the Role of Vascular Endothelial Growth Factor-Related Molecules in Tumor Angiogenesis?
  The American Journal of Pathology, 1998
• Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis.
  Journal of Clinical Investigation, 1996
• Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
  Nature Medicine, 1995
• Vasculogenesis
  Annual Review of Cell and Developmental Biology, 1995
• Potentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agents
  International Journal of Cancer, 1994
• Requirement of Vascular Integrin α _v β ₃ for Angiogenesis
  Science, 1994
• Lymphatics in Primary Cutaneous Melanoma
  The American Journal of Surgical Pathology, 1990
• Induction of angiogenesis during the transition from hyperplasia to neoplasia
  Nature, 1989